Over the years, the fields of bone, muscle and joint diseases have undergone enormous expansion in clinical and basic data, as well as that of field-related technology. With the problem of bone, muscle and joint diseases reaching epidemiological dimensions, treatment possibilities have digressed diversely. This development has created a need for debates and discussions on the numerous controversial issues to attain clinical conclusions.
The 3rd edition of BMJD aims to continue facilitating effective debates on unresolved clinical and therapeutic dilemmas, supported by evidence-based medicine and expert opinions resulting in agreement on timely issues. The program provides an effective forum for discussing and debating such unresolved controversies by allowing ample time for speaker-audience discussions with world authorities in the fields of Osteoporosis, Osteoarthritis, Rheumatoid Arthritis, Pain, Muscle and Joint Diseases.